Feedback control of p53 translation by REDD1 and mTORC1 limits the p53-dependent DNA damage response

Molecular and Cellular Biology

Volumn 31, Issue 21, 2011, Pages 4356-4365

  Vadysirisack, Douangsone D ^a   Baenke, Franziska ^a   Ory, Benjamin ^a,b   Lei, Kui ^a   Ellisen, Leif W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CHEMOSENSITIVITY; DNA DAMAGE; DNA REPAIR; EMBRYO; FEEDBACK SYSTEM; GENE; GENE FUNCTION; GENE INDUCTION; IONIZING RADIATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; REGG1 GENE; SENSITIVITY ANALYSIS;

ANIMALS; ANIMALS, NEWBORN; BRAIN; DNA DAMAGE; FEEDBACK, PHYSIOLOGICAL; GENES, P53; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PROTEIN BIOSYNTHESIS; PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 83255186748     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05541-11     Document Type: Article

References (37)

1. Brugarolas, J., et al. 2004. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 18:2893-2904.
2. Chen, K., A. Albano, A. Ho, and J. F. Keaney, Jr. 2003. Activation of p53 by oxidative stress involves platelet-derived growth factor-beta receptor-mediated ataxia telangiectasia mutated (ATM) kinase activation. J. Biol. Chem. 278:39527-39533.
3. Chen, X., L. J. Ko, L. Jayaraman, and C. Prives. 1996. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10:2438-2451.
4. Corradetti, M. N., K. Inoki, and K. L. Guan. 2005. The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway. J. Biol. Chem. 280:9769-9772.
5. Decaux, O., et al. 2010. Inhibition of mTORC1 activity by REDD1 induction in myeloma cells resistant to bortezomib cytotoxicity. Cancer Sci. 101:889-897.
6. DeYoung, M. P., P. Horak, A. Sofer, D. Sgroi, and L. W. Ellisen. 2008. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev. 22:239-251.
7. Dickson, A. J., and C. I. Pogson. 1980. Polyribosomes in isolated liver cells. Preparative procedures, effects of incubation and correlation with protein synthesis. Biochem. J. 186:35-45.
8. Ellisen, L. W., et al. 2002. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol. Cell 10:995-1005.
9. Fernandez-Capetillo, O., A. Lee, M. Nussenzweig, and A. Nussenzweig. 2004. H2AX: the histone guardian of the genome. DNA Repair (Amst.) 3:959-967.
10. Florenes, V. A., et al. 1994. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status. J. Natl. Cancer Inst. 86:1297-1302.
11. Fu, L., and S. Benchimol. 1997. Participation of the human p53 3UTR in translational repression and activation following gamma-irradiation. EMBO J. 16:4117-4125.
12. Harris, S. L., and A. J. Levine. 2005. The p53 pathway: positive and negative feedback loops. Oncogene 24:2899-2908.
13. Horak, P., et al. 2010. Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 107:4675-4680.
14. Huang, J., and B. D. Manning. 2009. A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem. Soc. Trans. 37:217-222.
15. Huang, S., and P. J. Houghton. 2003. Targeting mTOR signaling for cancer therapy. Curr. Opin. Pharmacol. 3:371-377.
16. Karawajew, L., P. Rhein, G. Czerwony, and W. D. Ludwig. 2005. Stressinduced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species. Blood 105:4767-4775.
17. Kenzelmann Broz, D., and L. D. Attardi. 2010. In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models. Carcinogenesis 31:1311-1318.
18. Lee, C. H., et al. 2007. Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53. EMBO J. 26:4812-4823.
19. Lowe, S. W., and H. E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7:535-545.
20. Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849.
21. Lu, C., and W. S. El-Deiry. 2009. Targeting p53 for enhanced radio-and chemo-sensitivity. Apoptosis 14:597-606.
22. Malagelada, C., Z. H. Jin, and L. A. Greene. 2008. RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/ activation. J. Neurosci. 28:14363-14371.
23. Montes de Oca Luna, R., D. S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378:203-206.
24. Puzio-Kuter, A. M., et al. 2009. Inactivation of p53 and Pten promotes invasive bladder cancer. Genes Dev. 23:675-680.
25. Reiling, J. H., and E. Hafen. 2004. The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila. Genes Dev. 18:2879-2892.
26. Riley, T., E. Sontag, P. Chen, and A. Levine. 2008. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell. Biol. 9:402-412.
27. Schwarzer, R., et al. 2005. REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase. Oncogene 24:1138-1149.
28. Shaulian, E., A. Zauberman, D. Ginsberg, and M. Oren. 1992. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12:5581-5592.
29. Shoshani, T., et al. 2002. Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol. Cell. Biol. 22:2283-2293.
30. Sofer, A., K. Lei, C. M. Johannessen, and L. W. Ellisen. 2005. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol. Cell. Biol. 25:5834-5845.
31. Takagi, M., M. J. Absalon, K. G. McLure, and M. B. Kastan. 2005. Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123:49-63.
32. Tyner, S. D., et al. 2002. p53 mutant mice that display early ageing-associated phenotypes. Nature 415:45-53.
33. Vousden, K. H., and C. Prives. 2009. Blinded by the light: the growing complexity of p53. Cell 137:413-431.
34. Wood, K. A., and R. J. Youle. 1995. The role of free radicals and p53 in neuron apoptosis in vivo. J. Neurosci. 15:5851-5857.
35. Wulf, G. M., Y. C. Liou, A. Ryo, S. W. Lee, and K. P. Lu. 2002. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J. Biol. Chem. 277:47976-47979.
36. Yang, D. Q., M. J. Halaby, and Y. Zhang. 2006. The identification of an internal ribosomal entry site in the 5-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage. Oncogene 25:4613-4619.
37. Yecies, J. L., and B. D. Manning. 2011. mTOR links oncogenic signaling to tumor cell metabolism. J. Mol. Med. 89:221-228.